Dual inhibition of HDAC and EGFR signaling with CUDC-101 induces potent suppression of tumor growth and metastasis in anaplastic thyroid cancer.
Oncotarget
Zhang, Lisa L; Zhang, Yaqin Y; Mehta, Amit A; Boufraqech, Myriem M; Davis, Sean S; Wang, Jing J; Tian, Ze Z; Yu, Zhiya Z; Boxer, Matthew B MB; Kiefer, Jeffrey A JA; Copland, John A JA; Smallridge, Robert C RC; Li, Zhuyin Z; Shen, Min M; Kebebew, Electron E